Official UK procurement notice
NP30925 Psychiatry and Neurology Medicines
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought2 lots · detail below
Published requirement descriptionSupply of psychiatry and neurology medicines to NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 36 bids on the busiest of 2 lots · 36 suppliers appointed
Lots and requirements (2)Procurement structure
2 lots · all with a published value · same evaluation weights on every lotLot #1Carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acidAwardedRenewalPublished value£1,973,036
Supply of carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier framework agreement per product line to seventeen (17) Framework Participants.
Lot #2All other psychiatry and neurology medicinesAwardedRenewalPublished value£39,713,504
Supply of other psychiatry and neurology medicines to NHS Scotland. The Authority intends to award the Framework Agreement as a single supplier framework agreement per line to thirty-three (33). Framework Participants.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Technical (Logistics): 5%
- price: 95%
Published award criteria (2)
- Technical (Logistics): 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement.
AND
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
AND
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
AND
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP30925 Psychiatry and Neurology Medicines” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 23 Apr 2025, 09:17 BST
- Last source update
- 18 Aug 2025, 08:53 BST
- Award evaluation window
- 23 May 2025 – …
- FTS notice number
2025/S 000-049343- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0505feFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) covers the thirty-six (36) month framework duration and the twelve (12) month extension period of the framework agreement. (SC Ref:805467)
How it was run
Official notice- Appointment period ends
- 23 May 2025, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 23 May 2025, 12:00 BST
Timeline
23 May 2025 → 18 Aug 2025 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown23 May 2025, 12:00 BST
- Bids opened23 May 2025, 12:00 BST
- Notice published18 Aug 2025, 08:53 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete18 Aug 2025, 08:53 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid
- Signed
- 25 Jul 2025
- Value
- £281,820
- Status
- active
All other psychiatry and neurology medicines
- Signed
- 25 Jul 2025
- Value
- £6,750,119
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Carbamazepine, lamotrigine, levodopa / carbidopa / entacapone, methylphenidate, phenytoin sodium, sodium valproate, and valproic acid | 36bids · 36 electronic · 36 from abroad | 0 | — | — |
| 2 · All other psychiatry and neurology medicines | 36bids · 36 electronic · 36 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Framework contractors & participating bidders
36 commercial parties on the notice- Accord-UK LtdFramework contractor
- Alturix LtdFramework contractor
- Amarox LimitedFramework contractor
- Aventis Pharma Ltd Trading As SanofiFramework contractor
- CST Pharma LtdFramework contractor
- Consilient Health LtdFramework contractor
- Crescent Pharma LimitedFramework contractor
- Flynn Pharma LtdFramework contractor
- Focus Pharmaceuticals LtdFramework contractor
- Galvany PharmaFramework contractor
Show 26 more suppliers
- GlaxoSmithKlineFramework contractor
- Hikma PharmaceuticalsFramework contractor
- Janssen Cilag LtdFramework contractor
- Kent Pharmaceuticals LtdFramework contractor
- Lundbeck LimitedFramework contractor
- Lupin (Europe) LimitedFramework contractor
- MSN LabsFramework contractor
- Macure Pharma ApsFramework contractor
- Martindale PharmaFramework contractor
- Medical ValleyFramework contractor
- Mercury Pharmaceuticals LimitedFramework contractor
- Necessity Supplies LtdFramework contractor
- Neuraxpharm UK LtdFramework contractor
- Novartis Pharmaceuticals UK LtdFramework contractor
- Novumgen LimitedFramework contractor
- Otsuka Pharmaceuticals (UK) LtdFramework contractor
- Pfizer LtdFramework contractor
- ROVI Biotech LimitedFramework contractor
- Ranbaxy (UK) LtdFramework contractor
- Roche Products LtdFramework contractor
- SERB SAFramework contractor
- STADA UK - Thornton & RossFramework contractor
- SandozFramework contractor
- Teva UK LtdFramework contractor
- Wockhardt UK LimitedFramework contractor
- ZentivaFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.